Innovative Advisory Group, LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Innovative Advisory Group, LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Buy	+6,998	New	+$946K	0.84%	13
2026 Q1	–	Sell	-21,787	Closed	-$2.66M	–	234
2025 Q4	$2.66M	Buy	+21,787	New	+$2.5M	1.69%	14

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Innovative Advisory Group, LLC's XBI Position: Q2 2026 in Review

Innovative Advisory Group, LLC opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 6,998 shares worth $1.11M. The stake represents 0.84% of the portfolio and ranks #13 among its holdings. This is a return to the name: Innovative Advisory Group, LLC previously reported a position in XBI as recently as Q4 2025.

Innovative Advisory Group, LLC first reported a position in XBI in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.66M in Q4 2025. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Innovative Advisory Group, LLC held 6,998 shares of State Street SPDR S&P Biotech ETF worth $1.11M as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Innovative Advisory Group, LLC position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.84% of Innovative Advisory Group, LLC's portfolio in Q2 2026, its #13 holding.
Innovative Advisory Group, LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 2 quarters since.
Innovative Advisory Group, LLC's State Street SPDR S&P Biotech ETF position peaked at $2.66M in Q4 2025.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Innovative Advisory Group, LLC's 13F filing for Q2 2026, filed 22 Sep 2026.